Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04293887
Recruitment Status : Not yet recruiting
First Posted : March 3, 2020
Last Update Posted : March 3, 2020
Information provided by (Responsible Party):
Zhao Jianping, Tongji Hospital

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : May 30, 2020
Estimated Study Completion Date : June 30, 2020
Publications of Results:
Other Publications: